648 related articles for article (PubMed ID: 7860733)
21. Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron.
Haut DD; Pintel DJ
Virology; 1999 May; 258(1):84-94. PubMed ID: 10329570
[TBL] [Abstract][Full Text] [Related]
22. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
23. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
24. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
25. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutations in brief no. 213. Online.
Ikezawa M; Nishino I; Goto Y; Miike T; Nonaka I
Hum Mutat; 1999; 13(2):170. PubMed ID: 10094556
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
[TBL] [Abstract][Full Text] [Related]
27. Purine-rich exon sequences are not necessarily splicing enhancer sequence in the dystrophin gene.
Ito T; Takeshima Y; Sakamoto H; Nakamura H; Matsuo M
Kobe J Med Sci; 2001 Oct; 47(5):193-202. PubMed ID: 11781497
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system.
Malueka RG; Yagi M; Awano H; Lee T; Dwianingsih EK; Nishida A; Takeshima Y; Matsuo M
Nucleic Acid Ther; 2011 Oct; 21(5):347-53. PubMed ID: 21967521
[TBL] [Abstract][Full Text] [Related]
29. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B.
Blanchette M; Chabot B
RNA; 1997 Apr; 3(4):405-19. PubMed ID: 9085847
[TBL] [Abstract][Full Text] [Related]
30. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
31. Nested introns in an intron: evidence of multi-step splicing in a large intron of the human dystrophin pre-mRNA.
Suzuki H; Kameyama T; Ohe K; Tsukahara T; Mayeda A
FEBS Lett; 2013 Mar; 587(6):555-61. PubMed ID: 23395799
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
Hodges D; Crooke ST
Mol Pharmacol; 1995 Nov; 48(5):905-18. PubMed ID: 7476922
[TBL] [Abstract][Full Text] [Related]
33. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
[TBL] [Abstract][Full Text] [Related]
34. A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.
Dwianingsih EK; Malueka RG; Nishida A; Itoh K; Lee T; Yagi M; Iijima K; Takeshima Y; Matsuo M
J Hum Genet; 2014 Aug; 59(8):423-9. PubMed ID: 24871807
[TBL] [Abstract][Full Text] [Related]
35. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.
Hagiwara Y; Nishio H; Kitoh Y; Takeshima Y; Narita N; Wada H; Yokoyama M; Nakamura H; Matsuo M
Am J Hum Genet; 1994 Jan; 54(1):53-61. PubMed ID: 8279470
[TBL] [Abstract][Full Text] [Related]
36. Optimizing splice-switching oligomer sequences using 2'-O-methyl phosphorothioate chemistry.
Adkin C; Fletcher S; Wilton SD
Methods Mol Biol; 2012; 867():169-88. PubMed ID: 22454061
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.
Arechavala-Gomeza V; Graham IR; Popplewell LJ; Adams AM; Aartsma-Rus A; Kinali M; Morgan JE; van Deutekom JC; Wilton SD; Dickson G; Muntoni F
Hum Gene Ther; 2007 Sep; 18(9):798-810. PubMed ID: 17767400
[TBL] [Abstract][Full Text] [Related]
38. Local dystrophin restoration with antisense oligonucleotide PRO051.
van Deutekom JC; Janson AA; Ginjaar IB; Frankhuizen WS; Aartsma-Rus A; Bremmer-Bout M; den Dunnen JT; Koop K; van der Kooi AJ; Goemans NM; de Kimpe SJ; Ekhart PF; Venneker EH; Platenburg GJ; Verschuuren JJ; van Ommen GJ
N Engl J Med; 2007 Dec; 357(26):2677-86. PubMed ID: 18160687
[TBL] [Abstract][Full Text] [Related]
39. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
Buvoli M; Buvoli A; Leinwand LA
PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
[TBL] [Abstract][Full Text] [Related]
40. Functional studies on the ATM intronic splicing processing element.
Lewandowska MA; Stuani C; Parvizpur A; Baralle FE; Pagani F
Nucleic Acids Res; 2005; 33(13):4007-15. PubMed ID: 16030351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]